Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis

Saudi Medical Journal

Volumn 34, Issue 7, 2013, Pages 719-726

  Shi, Hong Wei ^a   Pu, Peng ^a   Deng, Wei ^a   Zhou, Heng ^a   Bian, Zhou Yan ^a   Shen, Di Fei ^a   Xie, Jing ^a   Salerno, Michael ^b   Tang, Qi Zhu ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FOLLOW UP; HEART DEATH; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 84880728170     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thomas DE, Wheeler R, Yousef ZR, Masani ND. The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr 2009; 10: i15-i21
2. Fang W, Zhang J, He ZX. Myocardial ischemia in patients with dilated cardiomyopathy. Nucl Med Commun 2010; 31: 981-984
3. Hamilton RM, Azevedo ER. Sudden cardiac death in dilated cardiomyopathies. Pacing Clin Electrophysiol 2009; 32: S32-S40
4. Voss A, Fischer C, Schroeder R, Figulla HR, Goernig M. Lagged segmented Poincare plot analysis for risk stratification in patients with dilated cardiomyopathy. Med Biol Eng Comput 2012; 50: 727-736
5. Koutalas E, Kanoupakis E, Vardas P. Sudden cardiac death in non-ischemic dilated cardiomyopathy: A critical appraisal of existing and potential risk stratification tools. Int J Cardiol 2013;167: 335-341
6. Shekha K, Ghosh J, Thekkoott D, Greenberg Y. Risk stratification for sudden cardiac death in patients with non- ischemic dilated cardiomyopathy. Indian Pacing Electrophysiol J 2005; 5: 122-138
7. Okutucu S, Oto A. Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives. Cardiol J 2010; 17: 219-229
8. Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 727-732
9. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414-2421
10. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-28
11. Isbell DC, Kramer CM. The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy. Semin Ultrasound CT MR 2006; 27: 20-31
12. Karamitsos TD, Neubauer S. The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies. Curr Cardiol Rep 2013; 15: 326
13. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012; 5: 370-377
14. Yu L, Deng L, Li J, Zhang Y, Hu L. The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol 2013; 28: 391-396
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-560
16. MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
18. Hombach V, Merkle N, Torzewski J, Kraus JM, Kunze M, Zimmermann O, et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009; 30: 2011-2018
19. Leyva F, Taylor RJ, Foley PW, Umar F, Mulligan LJ, Patel K, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 2012; 60: 1659-1667
20. Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012; 5: 448-456
21. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842
22. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-1985
23. Masci PG, Barison A, Aquaro GD, Pingitore A, Mariotti R, Balbarini A, et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol 2012; 157: 43-47
24. Kono AK, Ishii K, Kumagai H, Taniguchi Y, Kajiya T, Sugimura K. Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy? Jpn J Radiol 2010; 28: 355-361
25. Looi JL, Edwards C, Armstrong GP, Scott A, Patel H, Hart H, et al. Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrast-enhanced cardiac magnetic resonance imaging. Clin Med Insights Cardiol 2010; 4: 129-134
26. Zimmermann O, Grebe O, Merkle N, Nusser T, Kochs M, Bienek-Ziolkowski M, et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail 2006; 8: 162-166
27. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487
28. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005; 111: 2837-2849
29. Babur GG, Karaahmet T, Tigen K. Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels. Anadolu Kardiyol Derg 2011; 11: 71-76
30. Sasaki T, Miller CF, Hansford R, Yang J, Caffo BS, Zviman MM, et al. Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mapping. Circ Arrhythm Electrophysiol 2012; 5: 1081-1090
31. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59
32. Basaran Y, Tigen K, Karaahmet T, Isiklar I, Cevik C, Gurel E, et al. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography 2011; 28: 62-68
33. Alter P, Rupp H, Adams P, Stoll F, Figiel JH, Klose KJ, et al. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2011; 13: 937-944
34. Zagrosek A, Abdel-Aty H, Boyé P, Wassmuth R, Messroghli D, Utz W, et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2009; 2: 131-138
35. Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. Eur Heart J 2012; 33: 640-648
36. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011; 57: 821-828